Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for k_a Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DOCKweb: a web-based GUI platform for molecular modeling with DOCK6.

Journal of computer-aided molecular design·2026

Same author

Solvent Effects on the Photophysical Properties of Unexplored Imidazo[1,2‑<i>a</i>]pyridine Derivatives.

ACS omega·2026

Same author

Expanding the Palette of Molecular Fragments for Small Molecule De Novo Design Through Isosteric Swapping.

Journal of computational chemistry·2026

Same author

Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set.

Journal of chemical information and modeling·2025

Same author

Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2024

Same author

Fragment and torsion biasing algorithms for construction of small organic molecules in proteins using DOCK.

Journal of computational chemistry·2024

Same journal

PSDTA: An Approach to Drug-Target Binding Affinity Prediction by Integrating Physicochemical and Structural Information to Reduce Feature Redundancy.

Journal of chemical information and modeling·2026

Same journal

M-JEPA: Predictive Self-Supervised Learning for Molecular Graphs with Scaffold-Shift Evaluation on Tox21.

Journal of chemical information and modeling·2026

Same journal

Advancing Biochemical Molecule Registration, Representation and Search for New Drug Modalities.

Journal of chemical information and modeling·2026

Same journal

A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation.

Journal of chemical information and modeling·2026

Same journal

Intricate Role of Cholesterol in Membrane Fusion.

Journal of chemical information and modeling·2026

Same journal

tmGNN-XAI: An Explainable Graph Neural Network Tool for Predicting Electronic Properties of Transition Metal Complexes from SMILES.

Journal of chemical information and modeling·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 16, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Descriptor-Driven de Novo Design Algorithms for DOCK6 Using RDKit.

Guilherme Duarte Ramos Matos^1,2, Steven Pak³, Robert C Rizzo^1,4,5

¹Department of Applied Mathematics & Statistics, Stony Brook University, Stony Brook, New York 11794, United States.

Journal of Chemical Information and Modeling

|September 12, 2023

Summary

This summary is machine-generated.

A new Descriptor-Driven De Novo (D3N) strategy in DOCK6 utilizes RDKit to design drug leads. This method guides molecule construction by calculating cheminformatics descriptors, enabling targeted chemical space exploration for drug discovery.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jul 16, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Area of Science:

Computational chemistry
Drug discovery
Cheminformatics

Background:

De novo design is crucial for discovering novel drug leads by constructing molecules computationally.
Existing methods may lack precise control over the chemical space explored during molecular construction.

Purpose of the Study:

To introduce and validate a Descriptor-Driven De Novo (D3N) strategy within the DOCK6 software.
To enable tailored ligand design by calculating user-defined cheminformatics descriptors during molecular growth.

Main Methods:

Integration of the RDKit toolkit into DOCK6 for on-the-fly descriptor calculations.
Implementation of the D3N strategy to guide ligand growth based on specified descriptor ranges.
Validation through comparison of descriptor calculations, analysis of descriptor distributions, and construction of ligands with tight descriptor constraints.

Main Results:

Robustness of the DOCK6/RDKit integration confirmed.
Demonstration of D3N's capability to direct molecular sampling within user-defined chemical spaces.
Successful construction of ligands with precise descriptor profiles, referencing clinically relevant compounds.

Conclusions:

The D3N strategy enhances DOCK6 for targeted drug-lead discovery.
On-the-fly descriptor calculations offer a powerful approach for designing ligands with desired properties.
This integration facilitates exploration of specific chemical spaces relevant to drug targets.